Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CDA Type I”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Testing effectiveness (Phase 2)UnknownNCT01295593
What this trial is testing

Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 33
Testing effectiveness (Phase 2)Study completedNCT00053027
What this trial is testing

Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 30
Early research (Phase 1)Study completedNCT00258271
What this trial is testing

Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
University of Rochester 18
Early research (Phase 1)UnknownNCT01439750
What this trial is testing

Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)

Who this might be right for
Mantle Cell Lymphoma
Milton S. Hershey Medical Center 13
Testing effectiveness (Phase 2)Ended earlyNCT03233724
What this trial is testing

Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas

Who this might be right for
Carcinoma, Non-Small-Cell LungLung CancerNon-Small Cell Lung Cancer+2 more
National Cancer Institute (NCI) 9
Early research (Phase 1)Study completedNCT00019071
What this trial is testing

Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00787969
What this trial is testing

Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 74
Early research (Phase 1)Study completedNCT03441048
What this trial is testing

Lintuzumab-Ac225 in Combination with Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Medical College of Wisconsin 26
Testing effectiveness (Phase 2)Temporarily pausedNCT02910752
What this trial is testing

CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia
Shanghai Jiao Tong University School of Medicine 20
Testing effectiveness (Phase 2)Study completedNCT00002879
What this trial is testing

Cladribine in Patients With Mantle Cell Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 51
Early research (Phase 1)Study completedNCT00003174
What this trial is testing

Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Barbara Ann Karmanos Cancer Institute 80
Post-approval studies (Phase 4)UnknownNCT01795794
What this trial is testing

Evaluation of the Efficacy in Decreasing Iron Absorption in Patients With Congenital Dyserythropoietic Anemia Type I by Treatment With LOSEC

Who this might be right for
CDA Type I
Soroka University Medical Center 12
Not applicableUnknownNCT01201135
What this trial is testing

GDF 15 in Sickle Cell Disease and Hereditary Spherocytosis

Who this might be right for
Patients With Thalassemia Intermedia,Congenital Dyserythropoietic Anemia Type I
Wolfson Medical Center 80
Testing effectiveness (Phase 2)Study completedNCT00072007
What this trial is testing

Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL

Who this might be right for
Leukemia
Swiss Cancer Institute 43
Early research (Phase 1)Study completedNCT00028418
What this trial is testing

Clofarabine in Chronic Lymphocytic Leukemia

Who this might be right for
Hematologic NeoplasmsLymphoproliferative DisordersLeukemia+1 more
M.D. Anderson Cancer Center 100